(VIANEWS) – Shares of Arcturus Therapeutics (NASDAQ: ARCT) jumped 5.51% to $28.71 at 09:55 EST on Wednesday, following the last session’s downward trend. NASDAQ is sliding 2.6% to $14,506.90, following the last session’s downward trend. This seems, at the moment, an all-around bearish trend trading session today.
Arcturus Therapeutics’s last close was $27.21, 78.06% under its 52-week high of $124.00.
Today’s last reported volume for Arcturus Therapeutics is 103638 which is 82.71% below its average volume of 599488.
Arcturus Therapeutics’s Sales
Arcturus Therapeutics’s sales growth is 625.3% for the ongoing quarter and 1814.2% for the next. The company’s growth estimates for the ongoing quarter is a negative 72.8% and positive 6.4% for the next.
Arcturus Therapeutics’s Revenue
Year-on-year quarterly revenue growth declined by 13.8%, now sitting on 8.7M for the twelve trailing months.
Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.18%, a negative 1.45%, and a positive 4.27%, respectively.
Arcturus Therapeutics’s highest amplitude of average volatility was 11.02% (last week), 4.51% (last month), and 4.27% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Arcturus Therapeutics’s stock is considered to be overbought (>=80).
Arcturus Therapeutics’s Stock Yearly Top and Bottom Value
Arcturus Therapeutics’s stock is valued at $28.71 at 09:56 EST, way under its 52-week high of $124.00 and way above its 52-week low of $24.87.
Arcturus Therapeutics’s Moving Average
Arcturus Therapeutics’s worth is way below its 50-day moving average of $40.67 and way below its 200-day moving average of $40.29.
More news about Arcturus Therapeutics (ARCT).